Parke-Davis Div of Pfizer Inc
NDC labeler code: 0071
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- EthosuximideZarontin · 2 products
- GabapentinNeurontin, Gralise, Relgaabi · 2 products
- PhenytoinDilantin, Phenytek, Phenytoin Infatabs · 1 product
- MethsuximideCelontin · 1 product
- Phenelzine sulfateNardil · 1 product
- PregabalinLyrica, Lyrica CR · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| December 30, 2004 | NDA021446 | Pregabalin LYRICA | Upjohn |
| March 2, 2000 | NDA021129 | Gabapentin NEURONTIN | Viatris |
| December 30, 1993 | NDA020235 | Gabapentin NEURONTIN | Viatris |
| February 26, 1979 | ANDA084427 | Phenytoin DILANTIN | Pharmacia |
| February 13, 1974 | ANDA080258 | Ethosuximide ZARONTIN | Parke-Davis |
| June 9, 1961 | NDA011909 | Phenelzine sulfate NARDIL | Parke Davis |
| November 2, 1960 | NDA012380 | Ethosuximide ZARONTIN | Parke Davis |
| February 8, 1957 | NDA010596 | Methsuximide CELONTIN | Parke Davis |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2019
-
September 12, 2019 · Class III · Terminated · D-0002-2020 · Ethosuximide
Labeling: Incorrect or Missing Lot and/or Exp Date. The expiry date on the product label is incorrect. The label states an expiry date of 09/2021 when it should be 09/2020.
Zarontin (ethosuximide capsules, USP) 250 mg, 100-count bottle, Rx Onl,y Made in Netherlands Distributed by Parke-Davis Division of Pfizer In NY, NY 10017, NDC 0071-0237-24
2016
-
January 11, 2016 · Class II · Terminated · D-0648-2016 · Pregabalin
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68
-
January 11, 2016 · Class II · Terminated · D-0649-2016 · Pregabalin
FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.
Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026